← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alida Biosciences, Inc.
San Diego, CA
$8,378,502
Total funding
8
Grants
Funding over time
peak $3.1M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,378,502 · 8
By mechanism
R44$7,256,731 · 4
R43$1,121,771 · 4
Investigators at Alida Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Pseudouridine detection with single-base resolution in a multiplexed epitranscriptomics assay$1,146,785
R44 · FY2025 · GM
Rapid NGS Method for Mapping of the Epitranscriptome$1,107,445
R44 · FY2024 · HG
Rapid NGS Method for Mapping of the Epitranscriptome$1,107,445
R44 · FY2023 · HG
Engineered RNA Modification Recognition$1,082,339
R44 · FY2024 · GM
Engineered RNA Modification Recognition$1,082,339
R44 · FY2025 · GM
Multiplexed Analysis of the Epitranscriptome$865,189
R44 · FY2024 · HG
Multiplexed Analysis of the Epitranscriptome$865,189
R44 · FY2023 · HG
Engineered RNA Modification Recognition$347,653
R43 · FY2023 · HG
Positional Marking of RNA Modifications$259,554
R43 · FY2022 · HG
Rapid NGS Method for Mapping of the Epitranscriptome$259,529
R43 · FY2022 · HG
Multiplexed Analysis of the Epitranscriptome$255,035
R43 · FY2021 · HG